Litcius/Paper detail

Portable Vertical Graphene@Au-Based Electrochemical Aptasensing Platform for Point-of-Care Testing of Tau Protein in the Blood

Yibiao Liu, Xingyun Liu, Mifang Li, Qiong Liu, Tailin Xu

2022Biosensors37 citationsDOIOpen Access PDF

Abstract

Alzheimer's disease (AD) is a long-term neurodegenerative disease that poses a serious threat to human life and health. It is very important to develop a portable quantitative device for AD diagnosis and personal healthcare. Herein, we develop a portable electrochemical sensing platform for the point-of-care detection of AD biomarkers in the blood. Such a portable platform integrates nanoAu-modified vertical graphene (VG@Au) into a working electrode, which can significantly improve sensitivity and reduce detection limit due to the large specific surface, excellent electrical conductivity, high stability, and good biocompatibility. The tau protein, as an important factor in the course of AD, is selected as a key AD biomarker. The results show that the linear range of this sensing platform is 0.1 pg/mL to 1 ng/mL, with a detection limit of 0.034 pg/mL (S/N = 3), indicating that this portable sensing platform meets the demand for the detection of the tau protein in the blood. This work offers great potential for AD diagnosis and personal healthcare.

Topics & Concepts

BiocompatibilityPoint of careGrapheneDetection limitBiomarkerBiomedical engineeringNanotechnologyComputer scienceMaterials sciencePoint-of-care testingMedicineChemistryPathologyChromatographyMetallurgyBiochemistryElectrochemical sensors and biosensorsElectrochemical Analysis and ApplicationsAdvanced biosensing and bioanalysis techniques
Portable Vertical Graphene@Au-Based Electrochemical Aptasensing Platform for Point-of-Care Testing of Tau Protein in the Blood | Litcius